Correlation Between Cognition Therapeutics and Acumen Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cognition Therapeutics and Acumen Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognition Therapeutics and Acumen Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cognition Therapeutics and Acumen Pharmaceuticals, you can compare the effects of market volatilities on Cognition Therapeutics and Acumen Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognition Therapeutics with a short position of Acumen Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognition Therapeutics and Acumen Pharmaceuticals.

Diversification Opportunities for Cognition Therapeutics and Acumen Pharmaceuticals

0.89

Correlation Coefficient

Cognition Therapeutics  Acumen Pharmaceuticals

Very poor diversification

The 3 months correlation between Cognition and Acumen is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Cognition Therapeutics and Acumen Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acumen Pharmaceuticals and Cognition Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognition Therapeutics are associated (or correlated) with Acumen Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acumen Pharmaceuticals has no effect on the direction of Cognition Therapeutics i.e., Cognition Therapeutics and Acumen Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cognition Therapeutics and Acumen Pharmaceuticals

Given the investment horizon of 90 days Cognition Therapeutics is expected to under-perform the Acumen Pharmaceuticals. In addition to that, Cognition Therapeutics is 1.17 times more volatile than Acumen Pharmaceuticals. It trades about -0.19 of its total potential returns per unit of risk. Acumen Pharmaceuticals is currently generating about -0.13 per unit of volatility. If you would invest  175.00  in Acumen Pharmaceuticals on December 29, 2024 and sell it today you would lose (52.00) from holding Acumen Pharmaceuticals or give up 29.71% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Cognition Therapeutics  vs.  Acumen Pharmaceuticals

Cognition Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cognition Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Acumen Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Cognition Therapeutics and Acumen Pharmaceuticals

The main advantage of trading using opposite Cognition Therapeutics and Acumen Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognition Therapeutics position performs unexpectedly, Acumen Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acumen Pharmaceuticals will offset losses from the drop in Acumen Pharmaceuticals' long position.

The idea behind Cognition Therapeutics and Acumen Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.